- Home
- PEPG vs PXLW Comparison
PEPG vs PXLW Comparison
Compare PEPG & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- PXLW
- Stock Information
- Founded
- PEPG 2018
- PXLW 1997
- Country
- PEPG United States
- PXLW United States
- Employees
- PEPG N/A
- PXLW N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- PXLW Semiconductors
- Sector
- PEPG Health Care
- PXLW Technology
- Exchange
- PEPG Nasdaq
- PXLW Nasdaq
- Market Cap
- PEPG 45.9M
- PXLW 50.2M
- IPO Year
- PEPG 2022
- PXLW 2000
- Fundamental
- Price
- PEPG $1.87
- PXLW $10.21
- Analyst Decision
- PEPG Buy
- PXLW Strong Buy
- Analyst Count
- PEPG 4
- PXLW 3
- Target Price
- PEPG $7.25
- PXLW $13.67
- AVG Volume (30 Days)
- PEPG 539.9K
- PXLW 169.2K
- Earning Date
- PEPG 11-06-2025
- PXLW 11-11-2025
- Dividend Yield
- PEPG N/A
- PXLW N/A
- EPS Growth
- PEPG N/A
- PXLW N/A
- EPS
- PEPG N/A
- PXLW N/A
- Revenue
- PEPG N/A
- PXLW $33,961,000.00
- Revenue This Year
- PEPG N/A
- PXLW N/A
- Revenue Next Year
- PEPG N/A
- PXLW $25.33
- P/E Ratio
- PEPG N/A
- PXLW N/A
- Revenue Growth
- PEPG N/A
- PXLW N/A
- 52 Week Low
- PEPG $0.88
- PXLW $4.67
- 52 Week High
- PEPG $10.06
- PXLW $15.03
- Technical
- Relative Strength Index (RSI)
- PEPG 71.39
- PXLW 52.04
- Support Level
- PEPG $1.35
- PXLW $10.07
- Resistance Level
- PEPG $2.10
- PXLW $13.50
- Average True Range (ATR)
- PEPG 0.17
- PXLW 1.38
- MACD
- PEPG 0.06
- PXLW 0.16
- Stochastic Oscillator
- PEPG 76.29
- PXLW 41.77
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.